University Hospitals Cleveland Medical Center — Cleveland, Ohio

Public research footprint of University Hospitals Cleveland Medical Center, compiled from the ClinicalTrials.gov public registry.

873

Registered studies

325

Active

200

Recruiting now

399

Completed

138

Stopped or withdrawn

Most-studied conditions

Acute Respiratory Distress Syndrome (ARDS) · Relapsed or Refractory B Cell Non-Hodgkin Lymphoma · Non-small Cell Lung Cancer · Metastatic Castration Sensitive Prostate Cancer (mCSPC)

Recently updated registry entries

NCT05784441 — A Study of JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL) (Active Not Recruiting)
NCT07071519 — A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative… (Recruiting)
NCT05531565 — A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University Hospitals Cleveland Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.